Latest Breaking News On - Erik kopp - Page 1 : comparemela.com

BioXcel Therapeutics Reports First Quarter 2024 Financial Results

BioXcel Therapeutics Reports First Quarter 2024 Financial Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesJapanVimal mehtaScott stachowiakBrennan doyleDavid schullErik koppSecurities exchangeAboutbioxceltherapeutics incWhile the companyNasdaqDrug administrationBioxcel therapeutics incDevelopment rd expensesXcel therapeutics reports first quarterXcel therapeutics

BioXcel Therapeutics to Report First Quarter 2024 Financial Results on May 9, 2024

BioXcel Therapeutics to Report First Quarter 2024 Financial Results on May 9, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Erik koppScott stachowiakBrennan doyleDavid schullWhile the companyBioxcel therapeutics incSecurities exchangeNasdaqAbut bioxcel therapeutics incXcel therapeuticsReport first quarterXcel therapeuticBioxcel therapeuticsOnkosxcel therapeuticsPrivate securities litigation reform actSecurities act

BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeting

BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeting
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesChicagoIllinoisAmericanLouism weinerErik koppBenjamin weinbergScott stachowiakBrennan doyleDavid schullDrug administrationRuesch centerMerck coBioxcel therapeutics incWhile the companyLombardi comprehensive cancer center

BioXcel Therapeutics Announces Plan for Evaluating BXCL501 in the At-Home Setting to Expand Its Market Potential

BioXcel Therapeutics Announces Plan for Evaluating BXCL501 in the At-Home Setting to Expand Its Market Potential
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Vincent oneillScott stachowiakMediarusso partnersdavid schullBrennan doyleErik koppBioxcel therapeutics incWhile the companyDrug administrationAboutbioxceltherapeutics inc bioxcel therapeuticsNasdaqSecurities exchangeProduct developmentXcel therapeuticsHome phaseVincento neillMedical officer

BioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501 for Agitation Associated With Alzheimer's Dementia -April 10, 2024 at 07:01 am EDT

Company plans to initiate trial following recent meeting with FDA No FDA-approved therapies for acute treatment of AAD are currently available NEW HAVEN, Conn., April 10, 2024 BioXcel.

Erik koppVincent oneillDavid schullBrennan doyleScott stachowiakNasdaqProduct developmentBioxcel therapeutics incSecurities exchangeGlobenewswire incWhile the companyBioxceltherapeutics incDrug administrationXcel therapeuticsCare phaseBreakthrough therapy